#oncology

Collection of oncology news, found 172 news.

Obesity linked to higher 5-year death rate after esophageal cancer surgery

Obesity linked to higher 5-year death rate after esophageal cancer surgery

  • 21st December 2011

Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

  • 20th November 2011

-         AstraZeneca today announced that the Marketing Authorisation Application ...

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

  • 16th November 2011

-                 - Updated international ...

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

  • 27th October 2011

-             CMC Biologics today announced the execution of an ...

Abbott to Separate into Two Leading Companies in Diversified Medical Products

Abbott to Separate into Two Leading Companies in Diversified Medical Products

  • 20th October 2011

-     Two publicly traded companies will offer shareholder distinct opportunities given unique ...

Roche and Diagnostica Stago Terminate Partnership

Roche and Diagnostica Stago Terminate Partnership

  • 4th October 2011

-         Roche Professional Diagnostics and Diagnostica Stago announced today that the ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

  • 5th September 2011

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

  • 5th September 2011

-        - This release is not intended for US ...

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

  • 5th September 2011

-        This Release is Not Intended for US Media        ...

CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

  • 5th September 2011

-        - This release is not intended for US and Canadian media    ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

  • 16th August 2011

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials

  • 13th July 2011

-Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of ...

Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery

Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery

  • 23rd June 2011

-       Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and ...

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

  • 20th June 2011

-    Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...